Early trial of Covid-19 vaccines by Pfizer, BioNtech promising: Scientists 0 02.07.2020 17:59 Business Standard The research said patients treated with the vaccine candidate produced nearly 1.8 to 2.8 fold greater levels of antibodies that could neutralise SARS-CoV-2 Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
